delta-crystalline of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

Details for Australian Patent Application No. 2006228027 (hide)

Owner Les Laboratoires Servier

Inventors Auguste, Marie-Noelle; Horvath, Stephane; Damien, Gerard

Agent Allens Arthur Robinson

Pub. Number AU-B-2006228027

Priority 05.10352 11.10.05 FR

Filing date 11 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 25 August 2011

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

26 October 2006 Complete Application Filed

  Priority application(s): 05.10352 11.10.05 FR

26 April 2007 Application Open to Public Inspection

  Published as AU-B-2006228027

25 August 2011 Application Accepted

  Published as AU-B-2006228027

8 September 2011 Application for Amendment

  The nature of the amendment is: Amend the invention title to read delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it. Address for service in Australia - Allens Arthur Robinson Patent & Trade Marks Attorneys Level 28 Deutsche Bank Place Corner Hunter and Phillip Streets Sydney NSW 2000

12 January 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228028-delta-d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

2006228026-RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)